CAU
EHC icon

Caxton Associates (UK)’s Encompass Health EHC Stock Holding History

Caxton Associates (UK)’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,519
Closed -$2.08M – 821
2026
Q1 		$2.08M Buy
+21,519
New +$2.21M 0.05% 207
2025
Q2 		– Sell
-2,561
Closed -$259K – 743
2025
Q1 		$259K Buy
+2,561
New +$250K 0.01% 659

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caxton Associates (UK)'s EHC Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 21,519 shares — an estimated $2.08M sold.

Caxton Associates (UK) first reported a position in EHC in Q1 2025 and held it in 2 quarters. The position peaked at $2.08M in Q1 2026. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 21,519 Encompass Health shares in Q2 2026, an estimated $2.08M.
  • Caxton Associates (UK) first reported a position in Encompass Health in Q1 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Encompass Health position peaked at $2.08M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.